Dava Stewart

Schizophrenia and rheumatoid arthritis appear to have a DNA level connection.

Patients who didn't respond to methotrexate may do well on baricitinib.

The FDA this week announced approval of Maci, “matrix-induced autologous chondrocyte implantation.” The treatment is intended for cartilage defects of the knee, which can eventually lead to osteoarthritis.

The authors say that for uveitis “there is a large unmet medical need" for identifying other therapies. Adalimumab is associated with decreased visual impairment and decreased risk of uveitic flare, but more adverse events, according the results from a recent multinational phase 3 trial.

The results of three Phase III trials indicate that ixekizumab is a safe and effective short term treatment for people with moderate-to-severe plaque-type psoriasis, according to a recent review of the existing literature.

Behcet's syndrome continues to puzzle rheumatologists.Several studies in 2014 and 2015 examined various aspects of this rare disorder.